ICON Public Limited Company (ICLR) Earnings Call Transcripts

58 earnings calls from January 2020 to July 30, 2026

NasdaqGS US Health Care Life Sciences Tools and Services

ICON Public Limited Company's Latest Earnings Call - Q4 FY2025

In the Q4 and full year 2025 earnings call, ICON Public Limited Company reported revenue of $2.1 billion for Q4, reflecting a 2.5% year-over-year increase, and full year revenue of $5 billion, up 0.8% from 2024. Adjusted earnings per share for Q4 was $2.52, down from $3.86 in the prior year, primarily due to a $50 million impact from revised cost-to-complete estimates. Management provided 2026 guidance, projecting revenue between $7.85 billion and $8.15 billion and adjusted EPS between $10 and $11, indicating a cautious outlook amid ongoing challenges in the bookings environment and elevated cancellation activity.

Reported metrics

MetricValueContext
Q4 Revenue $2.1 billion (beat) vs $2.0 billion est, +2.5% YoY
Full Year Revenue $5 billion (inline) vs $4.95 billion est, +0.8% YoY
Adjusted EPS Q4 $2.52 (miss) vs $3.86 YoY, down 34.8%
Adjusted EBITDA Margin Q4 15.5% (miss) vs 20.4% in Q4 2024
Net Bookings Q4 $2.9 billion (positive) up 19% YoY
Cancellations Q4 $365 million (positive) down from elevated levels in prior quarters

Guidance from management

Management expects 2026 revenue to range between $7.85 billion and $8.15 billion, with adjusted EPS between $10 and $11, reflecting a cautious outlook amid ongoing challenges in the bookings environment.

What management said

Both fair questions, Eric, and apologies if there was issues on the line. The impact to Q4 was north of $50 million. And the answer is those dollars get redistributed across the lifetime of those projects. These are not revenue dollars or margin dollars that disappear. They simply get rephased across what are relatively long-term contracts. So there was a follow-up question on what's the impact of the investigation o...
— Barry Balfe, Q4 FY2025 earnings call
I would second that, Mike. When we think about how we manage those things that are within our control, we structure our investments accordingly. We make sure that we're reallocating capital to the highest priorities, but also to ensure that this company isn't just doing what we said we'd do. We're doing it incrementally better on a quarter-over-quarter basis, and we very much have that in mind when we set the expecta...
— Barry Balfe, Q4 FY2025 earnings call

What analysts pressed on

Analysts expressed concerns about the sustainability of the improved win rates and the impact of the backlog adjustments on future revenue. There were also questions regarding the visibility into pass-through revenue and how pricing pressures might affect margins moving forward.

Main topics on the call

Read the full ICON Public Limited Company transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

About ICON Public Limited Company

ICON Public Limited Company (ICLR) is a publicly listed company in the Life Sciences Tools and Services industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 58 calls on record spanning January 14, 2020 to July 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 58 ICON Public Limited Company earnings call transcripts on record, spanning January 14, 2020 to July 30, 2026. Based on this history, ICON Public Limited Company reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ICLR
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Life Sciences Tools and Services
Calls on record
58
First call
January 14, 2020
Most recent
July 30, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 30, 2026 Read transcript
Q1 FY2026 Jun 24, 2026 Read transcript
Q4 FY2025 May 28, 2026 Read transcript
Company Conference Presentations Nov 19, 2025 Read transcript
Q3 FY2025 Oct 23, 2025 Read transcript
Q2 FY2025 Jul 24, 2025 Read transcript
Company Conference Presentations Mar 13, 2025 Read transcript
Q4 FY2024 Feb 20, 2025 Read transcript
Special Calls Jan 17, 2025 Read transcript
Company Conference Presentations Jan 14, 2025 Read transcript
Company Conference Presentations Nov 21, 2024 Read transcript
Q3 FY2024 Oct 24, 2024 Read transcript
Company Conference Presentations Sep 10, 2024 Read transcript
Q2 FY2024 Jul 25, 2024 Read transcript
Company Conference Presentations Jun 6, 2024 Read transcript
Analyst/Investor Day May 30, 2024 Read transcript
Q1 FY2024 Apr 25, 2024 Read transcript
Company Conference Presentations Mar 12, 2024 Read transcript
Company Conference Presentations Mar 5, 2024 Read transcript
Q4 FY2023 Feb 22, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Company Conference Presentations Nov 29, 2023 Read transcript
Company Conference Presentations Nov 14, 2023 Read transcript
Q3 FY2023 Oct 26, 2023 Read transcript
Company Conference Presentations Sep 26, 2023 Read transcript
Q2 FY2023 Jul 27, 2023 Read transcript
Company Conference Presentations Jun 6, 2023 Read transcript
Q1 FY2023 Apr 27, 2023 Read transcript
Company Conference Presentations Mar 15, 2023 Read transcript
Company Conference Presentations Mar 2, 2023 Read transcript
Q4 FY2022 Feb 23, 2023 Read transcript
Company Conference Presentations Jan 11, 2023 Read transcript
Q3 FY2022 Nov 3, 2022 Read transcript
Special Calls Oct 13, 2022 Read transcript
Q2 FY2022 Jul 28, 2022 Read transcript
Q1 FY2022 Apr 28, 2022 Read transcript
Analyst/Investor Day Mar 17, 2022 Read transcript
Company Conference Presentations Feb 24, 2022 Read transcript
Special Calls Feb 23, 2022 Read transcript
Q4 FY2021 Feb 22, 2022 Read transcript
Company Conference Presentations Jan 12, 2022 Read transcript
Company Conference Presentations Nov 9, 2021 Read transcript
Q3 FY2021 Nov 4, 2021 Read transcript
Q2 FY2021 Jul 22, 2021 Read transcript
Company Conference Presentations May 24, 2021 Read transcript
Company Conference Presentations May 12, 2021 Read transcript
Q1 FY2021 Apr 29, 2021 Read transcript
Company Conference Presentations Mar 10, 2021 Read transcript
Q4 FY2020 Feb 24, 2021 Read transcript
Company Conference Presentations Jan 12, 2021 Read transcript
Company Conference Presentations Nov 9, 2020 Read transcript
Q3 FY2020 Oct 22, 2020 Read transcript
Q2 FY2020 Jul 23, 2020 Read transcript
Company Conference Presentations May 20, 2020 Read transcript
Q1 FY2020 Apr 23, 2020 Read transcript
Company Conference Presentations Mar 10, 2020 Read transcript
Q4 FY2019 Feb 20, 2020 Read transcript
Company Conference Presentations Jan 14, 2020 Read transcript